Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.55
EXAC's Cash to Debt is ranked higher than
57% of the 518 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. EXAC: 0.55 )
EXAC' s 10-Year Cash to Debt Range
Min: 0.03   Max: No Debt
Current: 0.55

Equity to Asset 0.78
EXAC's Equity to Asset is ranked higher than
82% of the 477 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. EXAC: 0.78 )
EXAC' s 10-Year Equity to Asset Range
Min: 0.39   Max: 0.88
Current: 0.78

0.39
0.88
Interest Coverage 23.65
EXAC's Interest Coverage is ranked higher than
56% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 241.11 vs. EXAC: 23.65 )
EXAC' s 10-Year Interest Coverage Range
Min: 6.39   Max: 9999.99
Current: 23.65

6.39
9999.99
F-Score: 7
Z-Score: 5.48
M-Score: -2.32
WACC vs ROIC
11.96%
8.31%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 10.44
EXAC's Operating margin (%) is ranked higher than
84% of the 492 Companies
in the Global Medical Devices industry.

( Industry Median: 5.14 vs. EXAC: 10.44 )
EXAC' s 10-Year Operating margin (%) Range
Min: 6.73   Max: 20.53
Current: 10.44

6.73
20.53
Net-margin (%) 6.65
EXAC's Net-margin (%) is ranked higher than
81% of the 492 Companies
in the Global Medical Devices industry.

( Industry Median: 3.47 vs. EXAC: 6.65 )
EXAC' s 10-Year Net-margin (%) Range
Min: 4.3   Max: 11.59
Current: 6.65

4.3
11.59
ROE (%) 7.94
EXAC's ROE (%) is ranked higher than
79% of the 486 Companies
in the Global Medical Devices industry.

( Industry Median: 4.76 vs. EXAC: 7.94 )
EXAC' s 10-Year ROE (%) Range
Min: 5.87   Max: 14.39
Current: 7.94

5.87
14.39
ROA (%) 6.26
EXAC's ROA (%) is ranked higher than
84% of the 520 Companies
in the Global Medical Devices industry.

( Industry Median: 1.86 vs. EXAC: 6.26 )
EXAC' s 10-Year ROA (%) Range
Min: 3.9   Max: 10.56
Current: 6.26

3.9
10.56
ROC (Joel Greenblatt) (%) 14.11
EXAC's ROC (Joel Greenblatt) (%) is ranked higher than
78% of the 515 Companies
in the Global Medical Devices industry.

( Industry Median: 7.57 vs. EXAC: 14.11 )
EXAC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.7   Max: 25.63
Current: 14.11

8.7
25.63
Revenue Growth (3Y)(%) 4.50
EXAC's Revenue Growth (3Y)(%) is ranked higher than
76% of the 350 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. EXAC: 4.50 )
EXAC' s 10-Year Revenue Growth (3Y)(%) Range
Min: 4.5   Max: 30.5
Current: 4.5

4.5
30.5
EBITDA Growth (3Y)(%) 10.50
EXAC's EBITDA Growth (3Y)(%) is ranked higher than
84% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. EXAC: 10.50 )
EXAC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 2.4   Max: 38.1
Current: 10.5

2.4
38.1
EPS Growth (3Y)(%) 20.80
EXAC's EPS Growth (3Y)(%) is ranked higher than
88% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: -2.00 vs. EXAC: 20.80 )
EXAC' s 10-Year EPS Growth (3Y)(%) Range
Min: -8.3   Max: 34.6
Current: 20.8

-8.3
34.6
» EXAC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

EXAC Guru Trades in Q2 2014

Jim Simons 24,981 sh (+40.34%)
Mario Gabelli 675,440 sh (+1.35%)
Chuck Royce 848,119 sh (-8.21%)
» More
Q3 2014

EXAC Guru Trades in Q3 2014

Jim Simons 25,600 sh (+2.48%)
Chuck Royce 849,697 sh (+0.19%)
Mario Gabelli 665,287 sh (-1.50%)
» More
Q4 2014

EXAC Guru Trades in Q4 2014

Jim Simons 44,200 sh (+72.66%)
Mario Gabelli 642,687 sh (-3.40%)
Chuck Royce 807,697 sh (-4.94%)
Chuck Royce 807,697 sh (-4.94%)
» More
Q1 2015

EXAC Guru Trades in Q1 2015

Jim Simons 46,900 sh (+6.11%)
Mario Gabelli 644,552 sh (+0.29%)
Chuck Royce 780,227 sh (-3.40%)
» More
» Details

Insider Trades

Latest Guru Trades with EXAC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 18.30
EXAC's P/E(ttm) is ranked higher than
93% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 18.30 )
EXAC' s 10-Year P/E(ttm) Range
Min: 13.61   Max: 38.52
Current: 18.3

13.61
38.52
Forward P/E 16.47
EXAC's Forward P/E is ranked higher than
95% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 16.47 )
N/A
PE(NRI) 18.30
EXAC's PE(NRI) is ranked higher than
94% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 18.30 )
EXAC' s 10-Year PE(NRI) Range
Min: 13.63   Max: 38.52
Current: 18.3

13.63
38.52
P/B 1.40
EXAC's P/B is ranked higher than
92% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 3.92 vs. EXAC: 1.40 )
EXAC' s 10-Year P/B Range
Min: 1.11   Max: 4.67
Current: 1.4

1.11
4.67
P/S 1.20
EXAC's P/S is ranked higher than
87% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 4.21 vs. EXAC: 1.20 )
EXAC' s 10-Year P/S Range
Min: 0.85   Max: 3.54
Current: 1.2

0.85
3.54
PFCF 118.10
EXAC's PFCF is ranked higher than
80% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 118.10 )
EXAC' s 10-Year PFCF Range
Min: 14.45   Max: 353.86
Current: 118.1

14.45
353.86
POCF 13.20
EXAC's POCF is ranked higher than
93% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 13.20 )
EXAC' s 10-Year POCF Range
Min: 7.51   Max: 46.13
Current: 13.2

7.51
46.13
EV-to-EBIT 11.95
EXAC's EV-to-EBIT is ranked higher than
96% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 259.85 vs. EXAC: 11.95 )
EXAC' s 10-Year EV-to-EBIT Range
Min: 9.1   Max: 25.4
Current: 11.95

9.1
25.4
PEG 1.85
EXAC's PEG is ranked higher than
97% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 1.85 )
EXAC' s 10-Year PEG Range
Min: 1.18   Max: 4.5
Current: 1.85

1.18
4.5
Shiller P/E 22.50
EXAC's Shiller P/E is ranked higher than
95% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 22.50 )
EXAC' s 10-Year Shiller P/E Range
Min: 15.71   Max: 53.41
Current: 22.5

15.71
53.41
Current Ratio 4.91
EXAC's Current Ratio is ranked higher than
85% of the 514 Companies
in the Global Medical Devices industry.

( Industry Median: 2.67 vs. EXAC: 4.91 )
EXAC' s 10-Year Current Ratio Range
Min: 1.64   Max: 8.45
Current: 4.91

1.64
8.45
Quick Ratio 2.43
EXAC's Quick Ratio is ranked higher than
75% of the 514 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. EXAC: 2.43 )
EXAC' s 10-Year Quick Ratio Range
Min: 0.47   Max: 5.4
Current: 2.43

0.47
5.4
Days Inventory 358.30
EXAC's Days Inventory is ranked higher than
57% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 172.71 vs. EXAC: 358.30 )
EXAC' s 10-Year Days Inventory Range
Min: 330.22   Max: 566.06
Current: 358.3

330.22
566.06
Days Sales Outstanding 76.89
EXAC's Days Sales Outstanding is ranked higher than
74% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 84.05 vs. EXAC: 76.89 )
EXAC' s 10-Year Days Sales Outstanding Range
Min: 62.45   Max: 91
Current: 76.89

62.45
91

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 3.59
EXAC's Price/Net Current Asset Value is ranked higher than
95% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 3.59 )
EXAC' s 10-Year Price/Net Current Asset Value Range
Min: 1.87   Max: 18.45
Current: 3.59

1.87
18.45
Price/Tangible Book 1.65
EXAC's Price/Tangible Book is ranked higher than
93% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 7.90 vs. EXAC: 1.65 )
EXAC' s 10-Year Price/Tangible Book Range
Min: 1.37   Max: 4.7
Current: 1.65

1.37
4.7
Price/DCF (Projected) 1.65
EXAC's Price/DCF (Projected) is ranked higher than
92% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 1.65 )
EXAC' s 10-Year Price/DCF (Projected) Range
Min: 0.86   Max: 382.75
Current: 1.65

0.86
382.75
Price/Median PS Value 0.91
EXAC's Price/Median PS Value is ranked higher than
82% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. EXAC: 0.91 )
EXAC' s 10-Year Price/Median PS Value Range
Min: 0.68   Max: 2.46
Current: 0.91

0.68
2.46
Price/Peter Lynch Fair Value 1.94
EXAC's Price/Peter Lynch Fair Value is ranked higher than
98% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 1.94 )
EXAC' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.65   Max: 4.41
Current: 1.94

0.65
4.41
Price/Graham Number 1.15
EXAC's Price/Graham Number is ranked higher than
95% of the 580 Companies
in the Global Medical Devices industry.

( Industry Median: 0.00 vs. EXAC: 1.15 )
EXAC' s 10-Year Price/Graham Number Range
Min: 0.91   Max: 2.67
Current: 1.15

0.91
2.67
Earnings Yield (Greenblatt) 8.40
EXAC's Earnings Yield (Greenblatt) is ranked higher than
95% of the 505 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. EXAC: 8.40 )
EXAC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.9   Max: 10.9
Current: 8.4

3.9
10.9
Forward Rate of Return (Yacktman) 9.41
EXAC's Forward Rate of Return (Yacktman) is ranked higher than
85% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 4.29 vs. EXAC: 9.41 )
EXAC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2.9   Max: 15.8
Current: 9.41

2.9
15.8

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Exactech Inc was founded by an orthopaedic surgeon in November 1985, and is incorporated under the laws of the State of Florida. The Company develops, manufactures, markets, distributes and sella orthopaedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians in the United States and internationally. Its U.S. sales and distribution activities are conducted by its wholly owned subsidiary Exactech U.S., Inc. The Companys international development, sales and distribution activities are conducted by its wholly owned subsidiary Exactech International Operations, AG based in Bern, Switzerland. The Company manufactures some components of its knee, extremity, and hip joint replacement systems at its facility in Gainesville, Florida, utilizing modern, highly automated computer aided manufacturing equipment. Its cellular based manufacturing processes, which are organized in groups, or cells, are dedicated to specific product lines to minimize change-over and increase efficiency. To supplement its manufacturing of components, the company has formed strategic alliances with suppliers and business partners to externally manufacture some components. Additionally, the company acquires and distribute other products and services through exclusive agreements, such as its agreement with Tecres S.p.A, (Tecres) and Blue Ortho, SAS (Blue Ortho), and non-exclusive agreements, such as with RTI Surgical, Inc., (RTI), and Biomatlante SARL, (Biomatlante). The company markets its orthopaedic implant products in the United States through Exactech U.S., Inc. that operates through a network of independent sales agencies and direct sales representatives. The company offers its products in all fifty states, Puerto Rico, and the District of Columbia. The Companys competitors in the orthopaedic market are DePuy, Inc., a division of Johnson and Johnson, Zimmer, Inc., a subsidiary of Zimmer Holdings, Inc., Stryker Corporation, Smith and Nephew plc, and Biomet, Inc. The Companys operations are subject to numerous and increasingly stringent federal, state and local environmental laws and regulations in the United States and other countries in which they operates.
» More Articles for EXAC

Headlines

Articles On GuruFocus.com
What the Gurus Did This Week - Weekly Update on Guru Real Time Activity Jun 28 2013 
Mario Gabelli Ups His Holdings in EXAC, TWIN and LAYN Jun 28 2013 
comment on EXAC Oct 03 2011 
Exactech Inc. Reports Operating Results (10-K) Mar 16 2011 
Exactech Inc. Reports Operating Results (10-Q) Nov 09 2010 
Chuck Royce’s Top Predictable Companies: MEDNAX, Techne Corp., ITT Educational Services, Exactech May 17 2010 
Exactech Inc. Reports Operating Results (10-Q) May 05 2010 
Exactech Inc. (EXAC) CFO and Treasurer Joel C Phillips sells 2,497 Shares May 04 2010 
Exactech Inc. (EXAC) CEO and Chairman, 10% Owner R William Petty sells 20,000 Shares Dec 11 2009 
Exactech Inc. Reports Operating Results (10-Q) Nov 05 2009 

More From Other Websites
EXACTECH INC Financials May 15 2015
Coverage initiated on Exactech by Northland Capital May 14 2015
10-Q for Exactech, Inc. May 09 2015
EXACTECH INC Files SEC form 10-Q, Quarterly Report May 07 2015
EXACTECH INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 05 2015
Exactech posts 1Q profit Apr 28 2015
Exactech posts 1Q profit Apr 28 2015
EXACTECH INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Apr 28 2015
Exactech Q1 Revenue $61.4 Million. Net Income Down 2% to $4.1 Million. Diluted EPS $0.29 vs. $0.30. Apr 28 2015
EXACTECH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Apr 17 2015
Exactech Announces First Quarter 2015 Earnings Release Date and Updates First Quarter Estimates Apr 17 2015
Clinical Data on Exactech Technologies for Shoulder, Knee and Ankle Replacement Surgery Presented at... Mar 26 2015
Exactech Marks 30 Year Anniversary with Introduction of New Clinical Solutions for Improved Patient... Mar 24 2015
Exactech (EXAC) is in Overbought Territory: What's Next? - Tale of the Tape Mar 23 2015
10-K for Exactech, Inc. Mar 06 2015
EXACTECH INC Files SEC form 10-K, Annual Report Mar 04 2015
Exactech (EXAC) Q4 Earnings Top, Revenues Miss Estimates - Analyst Blog Feb 19 2015
Exactech posts 4Q profit Feb 17 2015
Exactech posts 4Q profit Feb 17 2015
EXACTECH INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Feb 17 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK